VBI Vaccines Price To Book vs. Price To Earning

Based on VBI Vaccines' profitability indicators, VBI Vaccines may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess VBI Vaccines' ability to earn profits and add value for shareholders.
For VBI Vaccines profitability analysis, we use financial ratios and fundamental drivers that measure the ability of VBI Vaccines to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well VBI Vaccines utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between VBI Vaccines's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of VBI Vaccines over time as well as its relative position and ranking within its peers.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

VBI Vaccines Price To Earning vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining VBI Vaccines's current stock value. Our valuation model uses many indicators to compare VBI Vaccines value to that of its competitors to determine the firm's financial worth.
VBI Vaccines is rated below average in price to book category among its peers. It is rated below average in price to earning category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value VBI Vaccines by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

VBI Price To Earning vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

VBI Vaccines

P/B

 = 

MV Per Share

BV Per Share

 = 
1.24 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

VBI Vaccines

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
(3.79) X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

VBI Price To Earning Comparison

VBI Vaccines is currently under evaluation in price to earning category among its peers.

VBI Vaccines Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in VBI Vaccines, profitability is also one of the essential criteria for including it into their portfolios because, without profit, VBI Vaccines will eventually generate negative long term returns. The profitability progress is the general direction of VBI Vaccines' change in net profit over the period of time. It can combine multiple indicators of VBI Vaccines, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts. Vbi Vaccines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 149 people.

VBI Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on VBI Vaccines. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of VBI Vaccines position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the VBI Vaccines' important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in VBI Vaccines without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Sync Your Broker Now

   

Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module

Use Investing Themes to Complement your VBI Vaccines position

In addition to having VBI Vaccines in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Broad Municipals ETFs Thematic Idea Now

Broad Municipals ETFs
Broad Municipals ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Municipals ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Municipals ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in VBI Stock

If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios